Most Read Articles
Stephen Padilla, 06 Aug 2020
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
06 Aug 2020
Sodium–glucose cotransporter-2 (SGLT-2) inhibitors increase the risk for diabetic ketoacidosis (DKA) by almost threefold, with molecule-specific analyses suggesting a class effect, according to a study.
Stephen Padilla, 3 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.

High hs-CRP levels in hyperuricaemic patients linked to increased long-term CHD risk

17 Nov 2019

There appears to be a borderline positive association between high-sensitivity C-reactive protein (hs-CRP) and long-term risk of coronary heart disease (CHD) among middle-aged and elderly individuals with hyperuricaemia, a study reports.

The cross-sectional study evaluated the 10-year CHD risk in 517 hyperuricaemic patients (84.7 percent male) aged 40–85 years in relation to hs-CRP levels. Hyperuricaemia was based on uric acid concentrations: ≥416 μmol/L for males and ≥360 μmol/L for females.

In the cohort, 193 patients (37.3 percent) had relatively high 10-year CHD risk, as measured using the Framingham risk score. The crude odds ratios (ORs) associated with the highest four vs lowest quintile of serum hs-CRP level were as follows: second, 1.43 (95 percent confidence interval [CI], 0.78–2.63; p=0.245); third, 2.05 (95 percent CI, 1.14–3.67; p=0.016); fourth, 2.77 (95 percent CI, 1.54–4.98; p=0.001); and fifth, 2.12 (95 percent CI, 1.18–3.80; p=0.012; p-trend=0.057).

The results did not change significantly following adjustments for several potential confounding factors, although the associations had become only borderline significant. The respective multivariable ORs for 10-year CHD in the second, third, fourth and fifth quintiles of serum hs-CRP level were 1.40 (95 percent CI, 0.75–2.61; p=0.291), 2.05 (95 percent CI, 1.13–3.72; p=0.019), 2.69 (95 percent CI, 1.47–4.89; p=0.001) and 2.10 (95 percent CI, 1.15–3.84; p=0.016) when compared with the lowest quintile (p-trend=0.068).

Despite the need for more research, the findings suggest that hs-CRP could serve as a marker for CHD risk in patients with hyperuricaemia, according to researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 06 Aug 2020
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
06 Aug 2020
Sodium–glucose cotransporter-2 (SGLT-2) inhibitors increase the risk for diabetic ketoacidosis (DKA) by almost threefold, with molecule-specific analyses suggesting a class effect, according to a study.
Stephen Padilla, 3 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.